DAVID CHAPLIN

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Oncotelic Therapeutics, Inc.

Filing Date Source Excerpt
2008-10-30 David Chaplin(1) Includes options to purchase 301,250 shares of common stock, which are exercisable within 60 days of October 24, 2008 (December 23, 2008) and 20,000 shares of unvested restricted common stock granted in 2005, which vest in equal annual installments over a four-year period, all of which are subject to transfer and forfeiture restrictions.
2010-11-12 David Chaplin(1) Includes options to purchase 462,500 shares of common stock, which are exercisable within 60 days of October 29, 2010 (December 28, 2010).
2011-02-18 David Chaplin(1) Includes options to purchase 511,250 shares of common stock, which are exercisable within 60 days of January 7, 2011 (March 8, 2011).
2012-11-19 David Chaplin(1) 6,655 * (1) Mr. Chaplin's employment with the company ended on August 30, 2011.

Data sourced from SEC filings. Last updated: 2025-10-12